Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity S Lee, J Rauch, W Kolch International journal of molecular sciences 21 (3), 1102, 2020 | 577 | 2020 |
Raf family kinases: old dogs have learned new tricks D Matallanas, M Birtwistle, D Romano, A Zebisch, J Rauch, ... Genes & cancer 2 (3), 232-260, 2011 | 460 | 2011 |
Evaluating strategies to normalise biological replicates of Western blot data A Degasperi, MR Birtwistle, N Volinsky, J Rauch, W Kolch, ... PloS one 9 (1), e87293, 2014 | 227 | 2014 |
The secret life of kinases: functions beyond catalysis J Rauch, N Volinsky, D Romano, W Kolch Cell communication and signaling 9, 1-28, 2011 | 217 | 2011 |
Big signals from small particles: regulation of cell signaling pathways by nanoparticles J Rauch, W Kolch, S Laurent, M Mahmoudi Chemical reviews 113 (5), 3391-3406, 2013 | 190 | 2013 |
Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development A Shilo, VB Hur, P Denichenko, I Stein, E Pikarsky, J Rauch, W Kolch, ... Rna 20 (4), 505-515, 2014 | 114 | 2014 |
Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription J Rauch, E O'Neill, B Mack, C Matthias, M Munz, W Kolch, O Gires Cancer research 70 (4), 1679-1688, 2010 | 114 | 2010 |
Emergence of bimodal cell population responses from the interplay between analog single-cell signaling and protein expression noise MR Birtwistle, J Rauch, A Kiyatkin, E Aksamitiene, M Dobrzyński, JB Hoek, ... BMC systems biology 6, 1-12, 2012 | 97 | 2012 |
Allogenic antibody-mediated identification of head and neck cancer antigens J Rauch, M Ahlemann, M Schaffrik, B Mack, S Ertongur, M Andratschke, ... Biochemical and biophysical research communications 323 (1), 156-162, 2004 | 91 | 2004 |
Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics-based technology O Gires, M Münz, M Schaffrik, C Kieu, J Rauch, M Ahlemann, D Eberle, ... Cellular and Molecular Life Sciences CMLS 61, 1198-1207, 2004 | 88 | 2004 |
c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway J Rauch, K Moran-Jones, V Albrecht, T Schwarzl, K Hunter, O Gires, ... Cancer research 71 (13), 4664-4674, 2011 | 82 | 2011 |
HGF induces epithelial-to-mesenchymal transition by modulating the mammalian hippo/MST2 and ISG15 pathways J Farrell, C Kelly, J Rauch, K Kida, A Garcia-Munoz, N Monsefi, ... Journal of proteome research 13 (6), 2874-2886, 2014 | 79 | 2014 |
The complexities and versatility of the RAS-to-ERK signalling system in normal and cancer cells D Fey, D Matallanas, J Rauch, OS Rukhlenko, BN Kholodenko Seminars in cell & developmental biology 58, 96-107, 2016 | 75 | 2016 |
CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck O Gires, B Mack, J Rauch, C Matthias Biochemical and biophysical research communications 343 (1), 252-259, 2006 | 69 | 2006 |
Physiological Temperature Has a Crucial Role in Amyloid Beta in the Absence and Presence of Hydrophobic and Hydrophilic Nanoparticles M Ghavami, M Rezaei, R Ejtehadi, M Lotfi, MA Shokrgozar, B Abd Emamy, ... ACS Chemical Neuroscience 4, 375-378, 2013 | 67 | 2013 |
Dissecting RAF inhibitor resistance by structure-based modeling reveals ways to overcome oncogenic RAS signaling OS Rukhlenko, F Khorsand, A Krstic, J Rozanc, LG Alexopoulos, N Rauch, ... Cell systems 7 (2), 161-179. e14, 2018 | 63 | 2018 |
Cell type-specific activation of AKT and ERK signaling pathways by small negatively-charged magnetic nanoparticles J Rauch, W Kolch, M Mahmoudi Scientific reports 2 (1), 868, 2012 | 54 | 2012 |
Molecular characterization of the tumor-associated antigen AAA-TOB3 M Schaffrik, B Mack, C Matthias, J Rauch, O Gires Cellular and Molecular Life Sciences CMLS 63, 2162-2174, 2006 | 42 | 2006 |
MultiBac: from protein complex structures to synthetic viral nanosystems M Pelosse, H Crocker, B Gorda, P Lemaire, I Rauch, Jens and Berger BMC Biology 15 (1), 2581, 2017 | 35 | 2017 |
SEREX, Proteomex, AMIDA, and beyond: Serological screening technologies for target identification J Rauch, O Gires PROTEOMICS–Clinical Applications 2 (3), 355-371, 2008 | 30 | 2008 |